A Study to Determine Dose and Regimen of Durvalumab as Monotherapy or in Combination With Pomalidomide With or Without Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma
Clinical trial NCT02616640 · COMPLETED
Trial details
- NCT number
- NCT02616640
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-11
- Primary completion
- 2018-11-23
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.